Mesenchymal stem cells media
07 April, 2009 | Life Technologies
Invitrogen has launched a serum-free media (SFM) designed specifically to culture mesenchymal stem cells (MSCs), or stem cells derived from bone marrow. Stempro MSC SFM is claimed to overcome many challenges in MSC culture. In concert, Invitrogen also launched two kits designed to allow the differentiation of MSCs to either adipocytes (fat cells) or osteocytes (bone cells).
Amino acid analysis
07 April, 2009 | Waters Australia Pty Ltd
The MassTrak AAA Solution is a system designed for the reliable and reproducible analysis of physiological amino acids using ultraperformance liquid chromatography (UPLC).
Gel documentation systems
07 April, 2009 | FB Australia
The FUSION FX7 is the latest addition to the range of gel documentation systems from Vilber Lourmat, France.
Protein fragmentation for ion traps
07 April, 2009 | Bruker Pty Ltd
Bruker Daltonics has released ETD II, an ETD (electron transfer dissociation) module for its HCT-Ultra high-capacity ion traps.
Mouse ventilator
07 April, 2009 | SDR Scientific
Mice can be ventilated while myocardial infarctions are induced with the HSE-HA MiniVent.
MALDI mass spectrometer
07 April, 2009 | Shimadzu Scientific Instruments (Oceania) Pty Ltd
Shimadzu Scientific Instruments has updated its line of Axima MALDI TOF mass spectrometers with three systems to meet the needs of researchers with varying applications and budgets.
Chromatography automation kits
07 April, 2009 | Global Life Sciences Solutions
ÄKTApurifier systems have been designed for versatile, high-performance FPLC purification of proteins and peptides. There are four different core systems with essential functions for FPLC purification. The core systems have different sets of pumps and detectors. These core systems can be combined with ÄKTAdesign automation kits to provide customised solutions to specific needs.
Vibrio identification
07 April, 2009 | Dutec Diagnostics Pty Ltd
V. parahaemolyticus, V. vulnificus and V. cholerae genic bacteria, which can cause serious seafood poisoning. For the detection of those bacteria, conventional methods (TCBS) are long, require a heavy workload and are not very sensitive.
Detection platform for multiple pathogens
07 April, 2009 | Scientifix Pty Ltd
Seegene and Lab901 have announced an automated multi-pathogen walk-away detection platform for European hospitals. Based on the Seeplex multiplexing PCR system and ScreenTape gel electrophoresis detection system, this Seeplex/ScreenTape detection platform is being introduced to clinical and research laboratories in 10 countries across Europe.
DNA/RNA purification system
07 April, 2009 | Phenomenex Australia
Phenomenex’s Clarity QSP system for synthetic RNA and DNA purification uses trityl-on purification to deliver concentrated, full-length oligonucleotide sequences.
SDMS
07 April, 2009 | Waters Australia Pty Ltd
Waters has released the NuGenesis scientific data management system (SDMS) for the Business and Enterprise editions of the Microsoft Windows Vista operating system platform (32 bit, Service Pack 1). Waters NuGenesis SDMS 7.1 Service Release 3 (SR3) also supports Microsoft Office 2007 with SP1 and includes updates for SDMS Vision Publisher that allow it to be validated on Vista and Office 2007.
Aerosol barrier tips
07 April, 2009 | Interpath Services Pty Ltd
Aerosol Barrier Tips come in a rack with a hinged lid for easy access and can be used with multi-channel pipettes.
Add safety to pipetting
07 April, 2009 | Alere Australia
Safe-Cone filters prevent contamination of the pipettor and the sample.
Gel scalpels
07 April, 2009 | Lomb Scientific (Aust) Pty Ltd
Excise target bands without scratching the screen of UV transilluminators with the DNase and Rnase-free gel scalpels.
Cancer biomarkers evaluation
07 April, 2009 | Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories has released a technical note (tech note 5654A) describing the study of an evaluation of cancer biomarkers. In the study, Bio-Rad researchers evaluated the Bio-Plex suspension array system’s ability to detect the levels of nine biomarkers, which were selected for their potential clinical relevance to cancer development. The nine biomarkers: angiopoietin-2 (Ang-2), VEGF, PDGF-BB, leptin, PECAM-1, IL-8, follistatin, HGF and G-CSF were collected in sera from four different types of cancer patients.
